X4 Pharmaceuticals (XFOR) Acquisitions (2019)
X4 Pharmaceuticals (XFOR) reported Acquisitions of $52.8 million for Q4 2019, up 300.0% quarter-over-quarter from -$26.4 million in Q1 2019.
X4 Pharmaceuticals (XFOR) Acquisitions (2019) Analysis & Trends
X4 Pharmaceuticals has reported Acquisitions for 1 years, with the latest figure at $52.8 million in Q4 2019.
- For the quarter ending Q4 2019, Acquisitions changed N/A year-over-year to $52.8 million; the trailing twelve-month figure through Sep 2020 stood at $52.8 million (up 300.0% YoY), and the FY2019 full-year result was $26.4 million, changed N/A from the prior year.
- Acquisitions for Q4 2019 stood at $52.8 million, up from -$26.4 million in the prior quarter.
- The five-year high for Acquisitions was $52.8 million in Q4 2019, with the low at -$26.4 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 52.81 Mn |
| Mar 31, 2019 | -26.41 Mn |